Mark Worthington - Net Worth and Insider Trading
Mark Worthington Net Worth
The estimated net worth of Mark Worthington is at least $87,508 dollars as of 2024-05-21. Mark Worthington is the General Counsel of Athira Pharma Inc and owns about 34,452 shares of Athira Pharma Inc (ATHA) stock worth over $87,508. Details can be seen in Mark Worthington's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Worthington has not made any transactions after 2024-01-05 and currently still holds the listed stock(s).
Transaction Summary of Mark Worthington
Mark Worthington Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Worthington owns 1 companies in total, including Athira Pharma Inc (ATHA) .
Click here to see the complete history of Mark Worthington’s form 4 insider trades.
Insider Ownership Summary of Mark Worthington
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-01-05 | General Counsel |
Mark Worthington Latest Holdings Summary
Mark Worthington currently owns a total of 1 stock. Mark Worthington owns 34,452 shares of Athira Pharma Inc (ATHA) as of January 5, 2024, with a value of $87,508.
Latest Holdings of Mark Worthington
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-01-05 | 34,452 | 2.54 | 87,508 |
Holding Weightings of Mark Worthington
Mark Worthington Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Worthington has made a total of 3 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Athira Pharma Inc is the sale of 2,412 shares on January 5, 2024, which brought Mark Worthington around $7,019.
Insider Trading History of Mark Worthington
- 1
Mark Worthington Trading Performance
Mark Worthington Ownership Network
Mark Worthington Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Mark Worthington is the General Counsel of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Mark Worthington made 2 insider transaction in Athira Pharma Inc (ATHA) with a net sale of 4,824. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Kevin Church .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 795,698 shares were bought by its insiders, resulting in a net purchase of 769,170 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Mark Worthington Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Worthington. You might contact Mark Worthington via mailing address: C/o Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
